Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy‐mediated differentiation
British Journal of Pharmacology2017Vol. 174(23), pp. 4308–4328
Citations Over TimeTop 24% of 2017 papers
Abstract
Modulating autophagy-mediated differentiation may be a novel strategy for treating AMKL, and tetrandrine has the potential to be developed as a differentiation-inducing agent for AMKL chemotherapy.
Related Papers
- → Structure-function analysis of the role of megakaryoblastic leukemia 1 in megakaryocyte polyploidization(2022)2 cited
- THE CARDIOVASCULAR EFFECTS OF TETRANDRINE AND DEMETHYL-TETRANDRINE(1958)
- → #614 Megakaryocyte Growth and Development Factor (MGDF) and the growth and differentiation of the leukemic cells of Down Syndrome patients with megakaryoblastic leukemia(1997)
- Progress of Research on Anti-tumor Effect of Tetrandrine(2008)
- → Structure-function analysis of the role of megakaryoblastic leukemia 1 in megakaryocyte polyploidization.(2022)